OTCM
PRKWF
Market cap2.06bUSD
, Last price
Name
Parkway Life Real Estate Investment Trust
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Parkway Life Real Estate Investment Trust (PLife REIT) is recognized as one of Asia's foremost publicly listed healthcare REITs based on its significant asset holdings. The trust's investment strategy focuses on acquiring income-generating real estate and associated assets predominantly utilized for healthcare and related services. This comprehensive mandate covers hospitals, various medical facilities, and properties supporting healthcare research, education, and the production or warehousing of pharmaceuticals, medical goods, and devices. As of December 31, 2020, PLife REIT managed a robust and geographically diversified portfolio comprising 54 properties across the Asia Pacific region, with a total valuation of approximately S$2.02 billion. Its Singaporean assets include the largest collection of strategically located private hospitals: Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital. Furthermore, its Japanese holdings encompass 50 high-quality nursing home and care facilities situated in various prefectures. The trust also possesses strata-titled units within the MOB Specialist Clinics in Kuala Lumpur, Malaysia.
Key people
Non-Executive Independent Chairman of the Board · since 2017
Yean Chau Yong
Chief Executive Officer, Executive Director · since 2009
Chief Financial Officer, Chief Operating Officer · since 2025
Seak Sze Tan
Chief Investment Officer · since 2018
Annie Chen
Vice President, Head - Corporate Finance · since 2023
Nicole Chua
Vice President, Head - Legal and Compliance/ Strategic Human Resource Management · since 2022
Sam Ho
Vice President, Head - Strategic Planning · since 2024
Wayne Lee
Vice President, Head - Investment · since 2023
Patricia Ng
Vice President, Head - Finance · since 2018
Ling Cher Tan
Vice President, Head - Asset Management · since 2023
Chin Ping Teo
Vice President, Head - Projects · since 2018
Shawn Yap
Vice President, Head - Special Projects, Asset Management · since 2023
Zhi Lei Tan
Senior Manager, Head - Financial Accounting
Joint Company Secretary
Wan Mei Chan
Joint Company Secretary · since 2014
Muthanna Bin Abdullah
Non-Executive Director · since 2023
Chorng Ann Chow
Non-Executive Director · since 2023
Tomo Nagahiro
Non-Executive Director · since 2023
Prem Kumar Nair
Non-Executive Director · since 2023
Cheng Keow Goh
Non-Executive Independent Director · since 2024
Legal address
C/O HSBC Institutional Trust Services (Singapore) Limited
HSBC Building,21 Collyer Quay,#13-02
Singapore, 01 049320
SG
HSBC Building,21 Collyer Quay,#13-02
Singapore, 01 049320
SG
Headquarters
C/O Parkway Trust Management Ltd
United Square,101 Thomson Road,#28-03
Singapore, 01 307591
SG
United Square,101 Thomson Road,#28-03
Singapore, 01 307591
SG
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||